CLAIM CARD
The evidence base for aspirin's immune-modulating properties was assessed through a synthesis of systematic reviews, meta-analyses, and observational cohorts. A central finding from preclinical research indicates that aspirin, at a dose of 30 mg/kg/day, hastens the resolution of cellular inflammation in skeletal muscle following acute injury (Lu 2026). This mechanistic action is contrasted by data from human studies. These findings from indirect comparators contextualize the challenge in isolating a specific anti-inflammatory effect for aspirin within complex human physiology.
Evidence grade: exploratory
Contradiction status: none
Publication: 4ff5f065-8b09-4580-9cbc-da14dbcaa1fa
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Saeed 2026source_3Zhu 2026source_4Navarese 2026source_5Yan 2024